Sutro Biopharma, Inc. (STRO)

Sutro Biopharma, Inc. (STRO) is a healthcare company (biotechnology) based in the United States. The share price is $8.88, down 4.72% on the day, which values the company at $147.42M. Price as of 17 Nov 2026, 17:26 UTC, from Yahoo Finance.

Key facts

Share price
$8.88−4.72% today
Market value
$147.42M
Funk Score
48/100
200-week average
$28.7069% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Sutro Biopharma, Inc. in more detail

STRO trades at -1.5× next year's expected earnings, 3.3× sales. It sits 69% below its 200-week average of $28.70.

Over the last five fiscal years Sutro Biopharma, Inc. has compounded revenue 19.1% a year. Its Funk Score is 48 out of 100 (financial strength 3.1, profitability 2.8, growth 8.5, each out of 10).

In its favour: More cash than debt. Worth checking: Altman Z in the distress zone; Weak Piotroski score.

Sutro Biopharma, Inc. (STRO): questions and answers

What is Sutro Biopharma, Inc.'s market cap?

Sutro Biopharma, Inc. is valued at $147.42M at a share price of $8.88.

Is STRO above its 200-week moving average?

No. STRO is 69.1% below its 200-week average of $28.70. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Sutro Biopharma, Inc. growing?

Over the last five fiscal years Sutro Biopharma, Inc.'s revenue grew 19.1% a year.

Does STRO pay a dividend?

Sutro Biopharma, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Sutro Biopharma, Inc. (STRO) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/STRO

Underlying data: Yahoo Finance; company filings with the SEC.